BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23262399)

  • 1. Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
    Fowler CJ; Josefsson A; Thors L; Chung SC; Hammarsten P; Wikström P; Bergh A
    Biochim Biophys Acta; 2013 Oct; 1831(10):1579-87. PubMed ID: 23262399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.
    Thors L; Bergh A; Persson E; Hammarsten P; Stattin P; Egevad L; Granfors T; Fowler CJ
    PLoS One; 2010 Aug; 5(8):e12275. PubMed ID: 20808855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance.
    Josefsson A; Wikström P; Egevad L; Granfors T; Karlberg L; Stattin P; Bergh A
    Scand J Urol Nephrol; 2012 Aug; 46(4):247-57. PubMed ID: 22452635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and non-curative treatment.
    Josefsson A; Wikström P; Granfors T; Egevad L; Karlberg L; Stattin P; Bergh A
    Eur Urol; 2005 Oct; 48(4):577-83. PubMed ID: 15990221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.
    Chung SC; Hammarsten P; Josefsson A; Stattin P; Granfors T; Egevad L; Mancini G; Lutz B; Bergh A; Fowler CJ
    Eur J Cancer; 2009 Jan; 45(1):174-82. PubMed ID: 19056257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer.
    Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A
    Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
    Fowler CJ; Hammarsten P; Bergh A
    PLoS One; 2010 Dec; 5(12):e15205. PubMed ID: 21203460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma.
    El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS
    Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium?
    Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S
    Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
    Egertová M; Cravatt BF; Elphick MR
    Neuroscience; 2003; 119(2):481-96. PubMed ID: 12770562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence.
    Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M
    Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.
    Häggström J; Cipriano M; Forshell LP; Persson E; Hammarsten P; Stella N; Fowler CJ
    Prostate; 2014 Aug; 74(11):1107-17. PubMed ID: 24913716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
    Hammarsten P; Cipriano M; Josefsson A; Stattin P; Egevad L; Granfors T; Fowler CJ
    PLoS One; 2012; 7(10):e47994. PubMed ID: 23133535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-mount prostate sections reveal differential endoglin expression in stromal, epithelial, and endothelial cells with the development of prostate cancer.
    Kassouf W; Ismail HR; Aprikian AG; Chevalier S
    Prostate Cancer Prostatic Dis; 2004; 7(2):105-10. PubMed ID: 15175661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoglin (CD 105) as a potential prognostic factor in neuroblastoma.
    Ćavar S; Jelašić D; Seiwerth S; Milošević M; Hutinec Z; Mišić M
    Pediatr Blood Cancer; 2015 May; 62(5):770-5. PubMed ID: 25683142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
    Walentiny DM; Vann RE; Wiley JL
    Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.
    Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S
    Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of fatty acid amide hydrolase in women with polycystic ovary syndrome.
    Cui N; Yang Y; Xu Y; Zhang J; Jiang L; Hao G
    Gynecol Endocrinol; 2017 May; 33(5):368-372. PubMed ID: 28132572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma].
    Li Q; Zhang B; Peng P
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.